Obesity News and Research

Latest Obesity News and Research

American Botanical Council honors excellence in herbal medicine

The 6th Annual American Botanical Council Celebration and Awards Ceremony took place last night, honoring individuals and companies who influence the present and future of the herbal medicine movement. The ABC event is part of the annual Natural Products Expo West trade show and Nutracon scientific conference, held in Anaheim, California.

11 Mar 2011

Majority of men on ADT after prostatectomy gain weight during first year of therapy

Seventy per cent of men who received androgen-deprivation therapy (ADT) after surgery to remove their prostate gland gained significant weight in the first year, putting on an average of 4.2kg, according to a paper in the March issue of the urology journal BJUI.

11 Mar 2011

Gastric bypass patients tend to overuse alcohol

Patients who have had a gastric bypass operation take longer to process alcohol, potentially leading some of them to overindulge when drinking, according to the results of a new study in the February issue of the Journal of the American College of Surgeons.

11 Mar 2011

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for celiac disease

Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), to support the development of a novel antibody therapeutic for celiac disease.

11 Mar 2011

Seattle Children's Hospital inaugurates new dialysis unit

Today, timed with World Kidney Day, Seattle Children's Hospital announced the opening of its newly renovated dialysis unit. The unit will significantly improve patient comfort and safety compared to its predecessor facility, and includes an additional 630 square feet of space for a total of nearly 2,400 square feet.

11 Mar 2011

Scientists discover four new genetic variants in humans linked with NAFLD

Five genetic variants in humans - four new - associate with Nonalcoholic Fatty Liver Disease, according to a study published March 10 in PLoS Genetics.

10 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

USDA certifies O.N.E. Organic Coconut Water as 100% organic

O.N.E., One Natural Experience, a leading producer of all-natural healthy Coconut Water beverages, announced today that it is the first and only mainstay premium coconut water brand to be certified 100% organic for its 11.2 oz. and 1 liter pure Coconut Water offerings.

10 Mar 2011

Mother's poor or inadequate nutrition linked to overeating later in life

Providing further understanding of the link between low birth weights and obesity later in life, researchers found nutritionally deprived newborns are "programmed" to eat more because they develop less neurons in the region of the brain that controls food intake, according to an article published today in the journal, Brain Research.

10 Mar 2011

Health Dialog unveils new Shared Decision Making program for insomnia patients

Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.

10 Mar 2011

Researchers pinpoint a protein responsible for fat storage in the body

Scientists have shed light on why some people are apple-shaped and others are pear-shaped.

10 Mar 2011

NeuroDerm commences ND0611 Phase I/II trial to treat Parkinson's disease

NeuroDerm, Ltd. announced today the enrollment of the first group of patients in its Phase I/II clinical trial of ND0611, a new patch for the treatment of Parkinson's disease.

9 Mar 2011

Camp STAR to offer evidence-based therapy for children with ADHD

Camp STAR, the Chicago area's only summer camp offering evidence-based therapy for children with Attention Deficit/Hyperactivity Disorder and other behavioral, emotional and social difficulties, begins its fourth season in June.

9 Mar 2011

Atherotech announces Sponsorship Agreement with NLA

Aiming to boost advanced lipoprotein testing in lipid education and management, Atherotech Diagnostics Lab announces its Sponsorship Agreement with the National Lipid Association.

9 Mar 2011

NovaShunt raises Series B financing for CHF 23.7 million

NovaShunt AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23.7 million in a Series B preferred share financing round co-led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund.

9 Mar 2011

Three new research initiatives to study how design of neighbourhoods impact obesity

The Honourable Leona Aglukkaq, Minister of Health, today announced three new research initiatives studying how the design of neighbourhoods impact obesity. The studies were funded by the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada.

9 Mar 2011

Study: Americans experience higher rates of chronic disease than their English counterparts

Researchers announced today in the American Journal of Epidemiology that despite the high level of spending on healthcare in the United States compared to England, Americans experience higher rates of chronic disease and markers of disease than their English counterparts at all ages.

9 Mar 2011

Belly laugh best for venous leg ulcers

Forget technology. The best prescription for patients with venous leg ulcers is good quality nursing care - and the occasional belly laugh!

9 Mar 2011

FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus.

9 Mar 2011

Diabetes belt mapped out in the US

A government commissioned team of researchers has now identified a diabetes belt in the U.S. County-by-county mapping shows that the highest rates of diabetes cut two paths - one strung through Tennessee, Kentucky and West Virginia, and another running eastward from Louisiana through Mississippi, Alabama, Georgia and South Carolina. This belt also touches parts of North Carolina, Virginia, Florida, Texas, Arkansas, Ohio and Pennsylvania. High-diabetes pockets crop up in Oklahoma, Michigan, Arizona, the Dakotas and elsewhere. The belt includes 644 counties in 15 states with the highest diabetes rates.

8 Mar 2011